Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 6

Results: 8

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 525, doi. 10.1007/s40261-022-01163-5

By:

Megna, Matteo;
Patruno, Cataldo;
Bongiorno, Maria Rita;
Gambardella, Alessio;
Guarneri, Claudio;
Romita, Paolo;
Raimondo, Annunziata;
Loconsole, Francesco;
Fabbrocini, Gabriella

Publication type:

Article

Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 477, doi. 10.1007/s40261-022-01162-6

By:

Alten, Rieke;
An, Yoorim;
Kim, Dong-Hyeon;
Yoon, SangWook;
Peyrin-Biroulet, Laurent

Publication type:

Article

Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 533, doi. 10.1007/s40261-022-01161-7

By:

Barman, Hasan Ali;
Tanyolaç, Selim;
Dogan, Omer;
Bal, Erdem;
Atıcı, Adem;
Özyıldırım, Serhan;
Yiğit, Zerrin

Publication type:

Article

Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 501, doi. 10.1007/s40261-022-01160-8

By:

Abegaz, Tadesse M.;
Diaby, Vakaramoko;
Sherbeny, Fatimah;
Ali, Askal Ayalew

Publication type:

Article

Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 491, doi. 10.1007/s40261-022-01157-3

By:

Ionova, Yelena;
Vuong, Wilson;
Sandoval, Omar;
Fong, Jodie;
Vu, Vincent;
Zhong, Lixian;
Wilson, Leslie

Publication type:

Article

Rare Mycobacteria and HIV in Children: Two Case Reports.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 541, doi. 10.1007/s40261-022-01153-7

By:

Johnson, Sarah M.;
Piñera, Cecilia;
Whittaker, Elizabeth;
Kirkhope, Natalie;
Kon, Onn M.;
Satta, Giovanni;
Balcells, Maria Elvira;
Foster, Caroline

Publication type:

Article

A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 513, doi. 10.1007/s40261-022-01156-4

By:

Darwish, Mona;
Youakim, James M.;
Harlick, Jim;
DeKarske, Daryl;
Stankovic, Serge

Publication type:

Article

A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 6, p. 465, doi. 10.1007/s40261-022-01140-y

By:

Corbacioglu, Selim;
Topaloglu, Ozlem;
Aggarwal, Saurabh

Publication type:

Article